Skip to main content

Together we are beating cancer

Donate now

Henry Scowcroft

Henry Scowcroft is an award-winning science writer and author of Cross Everything, an acclaimed memoir about cancer. He worked at Cancer Research UK between 2003 and 2022, and is now a freelance communications consultant, writer and editor.
Showing 12 out of 276 results
Nicola and her children at home

Find out how, with thanks from Cancer Research UK scientists, bowel cancer treatment has "phenomenally" improved from when Nicola's mother had the disease. Find out how, with thanks from Cancer Research UK scientists, bowel cancer treatment has "phenomenally" improved from when Nicola's mother had the disease.

by Henry Scowcroft | Analysis | 23 July 2014

23 July 2014

New research on a couple of specialised imaging techniques could improve breast cancer screening in the future. New research on a couple of specialised imaging techniques could improve breast cancer screening in the future.

by Henry Scowcroft | Analysis | 27 June 2014

27 June 2014

We look at the science behind media stories about a 'simple blood test' that apparently can 'predict breast cancer'. We look at the science behind media stories about a 'simple blood test' that apparently can 'predict breast cancer'.

by Henry Scowcroft | Analysis | 27 June 2014

27 June 2014

The Government today took a crucial step towards standard packs... but we're not there quite yet. What still needs to happen? The Government today took a crucial step towards standard packs... but we're not there quite yet. What still needs to happen?

by Henry Scowcroft | Analysis | 26 June 2014

26 June 2014

A handshake
  • Science & Technology
  • Health & Medicine

New immunotherapy drugs hit the headlines - how do they work?

In the light of continued media attention, we explain the science behind two exciting new types of immunotherapy drug, called PD-1 and PD-L1 blockers. In the light of continued media attention, we explain the science behind two exciting new types of immunotherapy drug, called PD-1 and PD-L1 blockers.

by Henry Scowcroft | Analysis | 2 June 2014

2 June 2014

Newsstands
  • Science & Technology
  • Health & Medicine

News digest - inequalities, Wikipedia, low-cal diets and more

A look at the week's cancer news including 19,000 extra deaths due to social deprivation, inaccuracies in Wikipedia, low-cal diets for breast cancer and more. A look at the week's cancer news including 19,000 extra deaths due to social deprivation, inaccuracies in Wikipedia, low-cal diets for breast cancer and more.

by Henry Scowcroft | Analysis | 31 May 2014

31 May 2014

A new report links social inequality to more than 15,000 extra cases of cancer each year, and – even more alarmingly – more than 19,000 extra deaths. A new report links social inequality to more than 15,000 extra cases of cancer each year, and – even more alarmingly – more than 19,000 extra deaths.

by Henry Scowcroft | Analysis | 29 May 2014

29 May 2014

''Christian Charity'', oil on canvas painting by Giovanni Francesco Barbieri, called Il Guercino, c. 1625-26

Amidst widespread coverage of today's survival story, we were concerned to spot an error in a newspaper graphic, suggesting that breastfeeding caused cancer. Amidst widespread coverage of today's survival story, we were concerned to spot an error in a newspaper graphic, suggesting that breastfeeding caused cancer.

by Henry Scowcroft | Analysis | 29 April 2014

29 April 2014

Target
  • Science & Technology
  • Health & Medicine

The quest to unravel the side effects of cancer drugs

An important part of cancer drug treatment is minimising side effects - how are scientists tackling this issue and what does the new research show? An important part of cancer drug treatment is minimising side effects - how are scientists tackling this issue and what does the new research show?

by Henry Scowcroft | Analysis | 5 September 2013

5 September 2013

Headlines

Following reports that women who stop taking the breast cancer drug tamoxifen could face their cancer returning, we look at the research behind the headlines. Following reports that women who stop taking the breast cancer drug tamoxifen could face their cancer returning, we look at the research behind the headlines.

by Henry Scowcroft | Analysis | 4 September 2013

4 September 2013